Tissue-resident Eomeshi T-betlo CD56bright NK cells with reduced proinflammatory potential are enriched in the adult human liver

European Journal of Immunology

Volumn 46, Issue 9, 2016, Pages 2111-2120

  Harmon, Cathal ^a   Robinson, Mark W ^a   Fahey, Ronan ^a   Whelan, Sarah ^a   Houlihan, Diarmaid D ^b   Geoghegan, Justin ^b   O'Farrelly, Cliona ^a,c  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^c TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

CD56bright natural killer (NK) cells; Human liver; Interferon; Microenvironment; Tissue resident

Indexed keywords

CD56 ANTIGEN; CHEMOKINE RECEPTOR CXCR6; EOMESODERMIN; GAMMA INTERFERON; GRANZYME B; INTERLEUKIN 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL KILLER CELL RECEPTOR NKG2D; PERFORIN; TRANSCRIPTION FACTOR T BET;

ADULT; ARTICLE; BLOOD; CELL POPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DEGRANULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER; LIVER BIOPSY; LIVER TRANSPLANTATION; MICROENVIRONMENT; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION;

EID: 84985943054     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201646559     Document Type: Article

References (35)

1. Cooper, M. A., Fehniger, T. A. and Caligiuri, M. A., The biology of human natural killer-cell subsets. Trends Immunol. 2001. 22: 633–640.
2. Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E. et al., Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood 2001. 97: 3146–3151.
3. Serafini, N., Vosshenrich, C. A. J. and Di Santo, J. P., Transcriptional regulation of innate lymphoid cell fate. Nat. Rev. Immunol. 2015. 15: 415–28.
4. Leong, J. W., Wagner, J. A., Ireland, A. R. and Fehniger, T. A., Transcriptional and post-transcriptional regulation of NK cell development and function. Clin. Immunol. 2016, in press. doi: 10.1016/j.clim.2016.03.003.
5. Boos, M. D., Yokota, Y., Eberl, G. and Kee, B. L., Mature natural killer cell and lymphoid tissue–inducing cell development requires Id2-mediated suppression of E protein activity. J. Exp. Med. 2007. 204: 1119–1130.
6. Gordon, S. M., Chaix, J., Rupp, L. J., Wu, J., Madera, S., Sun, J. C., Lindsten, T. et al., The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. Immunity 2012. 36: 55–67.
7. Daussy, C., Faure, F., Mayol, K., Viel, S., Gasteiger, G., Charrier, E., Bienvenu, J. et al., T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J. Exp. Med. 2014. 211: 563–577.
8. Lysakova-Devine, T. and O'Farrelly, C., Tissue-specific NK cell populations and their origin. J. Leukoc. Biol. 2014. 96: 981–90.
9. Moffett-King, A., Natural killer cells and pregnancy. Nat. Rev. Immunol. 2002. 2: 656–63.
10. Björkström, N. K., Ljunggren, H.-G. and Michaëlsson, J., Emerging insights into natural killer cells in human peripheral tissues. Nat. Rev. Immunol. 2016. 16: 310–320.
11. Doherty, D. G., Norris, S., Madrigal-estebas, L., McEntee, G., Traynor, O., Hegarty, J. E. and O'Farrelly, C., The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns. J. Immunol. 1999. 163: 2314–2321.
12. Norris, S., Collins, C., Doherty, D. G., Smith, F., McEntee, G., Traynor, O., Nolan, N. et al., Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J. Hepatol. 1998. 28: 84–90.
13. Moroso, V., Metselaar, H. J., Mancham, S., Tilanus, H. W., Eissens, D., van der Meer, A., van der Laan, L. J. W. et al., Liver grafts contain a unique subset of natural killer cells that are transferred into the recipient after liver transplantation. Liver Transpl. 2010. 16: 895–908.
14. Marquardt, N., Beziat, V., Nystrom, S., Hengst, J., Ivarsson, M. A., Kekalainen, E., Johansson, H. et al., Identification and Characterization of Human Intrahepatic CD49a+ NK Cells. J. Immunol. 2015. 194: 2467–2471.
15. Hudspeth, K., Donadon, M., Cimino, M., Pontarini, E., Tentorio, P., Preti, M., Hong, M. et al., Human liver-resident CD56bright/CD16neg NK cells are retained within hepatic sinusoids via the engagement of CCR5 and CXCR6 pathways. J. Autoimmun. 2016. 66: 40–50.
16. Radaeva, S., Sun, R., Jaruga, B., Nguyen, V. T., Tian, Z. and Gao, B., Natural Killer Cells Ameliorate Liver Fibrosis by Killing Activated Stellate Cells in NKG2D-Dependent and Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand–Dependent Manners. Gastroenterology 2006. 130: 435–452.
17. Waggoner, S. N., Cornberg, M., Selin, L. K. and Welsh, R. M., Natural killer cells act as rheostats modulating antiviral T cells. Nature 2012. 481: 394–398.
18. Maini, M. K. and Peppa, D., NK cells: a double-edged sword in chronic hepatitis B virus infection. Front. Immunol. 2013. 4: 57. doi: 10.3389/fimmu.2013.00057.
19. Robinson, M. W., Harmon, C. and O'Farrelly, C., Liver immunology and its role in inflammation and homeostasis. Cell. Mol. Immunol. 2016. 13: 267–276.
20. Paust, S., Gill, H. S., Wang, B., Flynn, M. P., Ashley, E., Senman, B., Szczepanik, M. et al., Critical role for CXCR6 in NK cell-mediated antigen-specific memory to haptens and viruses. Nat. Immunol. 2011. 11: 1127–1135.
21. Stegmann, K. A., Robertson, F., Hansi, N., Gill, U., Pallant, C., Christophides, T., Pallett, L. J. et al., CXCR6 marks a novel subset of T-betloEomeshi natural killer cells residing in human liver. Sci. Rep. 2016. 6: 26157. doi: 10.1038/srep26157.
22. Shi, X., Moroso, V., Metselaar, H. J. and Kwekkeboom, J., Long-lived donor leukocytes or relocated donor hematopoietic stem/progenitor cells cause long-term hematopoietic chimerism after liver transplantation. Hepatology 2013. 56: 2542.
23. Golden-Mason, L., Curry, M. P., Nolan, N., Traynor, O., McEntee, G., Kelly, J., Hegarty, J. E. et al., Differential expression of lymphoid and myeloid markers on differentiating hematopoietic stem cells in normal and tumor-bearing adult human liver. Hepatology 2000. 31: 1251–1256.
24. Kelly, A. M., Golden-Mason, L., McEntee, G., Traynor, O., Doherty, D. G., Hegarty, J. E. and O'Farrelly, C., Interleukin 12 (IL-12) is increased in tumour bearing human liver and expands CD8(+) and CD56(+) T cells in vitro but not in vivo. Cytokine 2004. 25: 273–282.
25. Kelly, A. M., Golden-Mason, L., Traynor, O., Geoghegan, J., McEntee, G., Hegarty, J. E. and O'Farrelly, C., Changes in hepatic immunoregulatory cytokines in patients with metastatic colorectal carcinoma: implications for hepatic anti-tumour immunity. Cytokine 2006. 35: 171–179.
26. Golden-Mason, L., Kelly, A. M., Traynor, O., McEntee, G., Kelly, J., Hegarty, J. E. and O'Farrelly, C., Expression of interleukin 7 (IL-7) mRNA and protein in the normal adult human liver: implications for extrathymic T cell development. Cytokine 2001. 14: 143–151.
27. Martinez-llordella, M., Lozano, J.-J., Puig-pey, I., Orlando, G., Tisone, G., Lerut, J., Benitez, C. et al., Using transcriptional profiling to develop a diagnostic test of operational tolerance in liver transplant recipients. J. Clin. Invest. 2008. 118: 2845–2857.
28. Harmon, C., Sanchez-Fueyo, A., O'Farrelly, C. and Houlihan, D. D., Natural Killer Cells and Liver Transplantation: Orchestrators of Rejection or Tolerance? Am. J. Transplant. 2016. 16: 751–757.
29. Gao, B., Radaeva, S. and Park, O., Liver natural killer and natural killer T cells: immunobiology and emerging roles in liver diseases. J. Leukoc. Biol. 2009. 86: 513–528.
30. Peppa, D., Gill, U. S., Reynolds, G., Easom, N. J. W., Pallett, L. J., Schurich, A., Micco, L. et al., Up-regulation of a death receptor renders antiviral T cells susceptible to NK cell-mediated deletion. J. Exp. Med. 2013. 210: 99–114.
31. Cai, L., Zhang, Z., Zhou, L., Wang, H., Fu, J., Zhang, S., Shi, M. et al., Functional impairment in circulating and intrahepatic NK cells and relative mechanism in hepatocellular carcinoma patients. Clin. Immunol. 2008. 129: 428–437.
32. Jinushi, M., Takehara, T., Tatsumi, T., Hiramatsu, N., Sakamori, R., Yamaguchi, S. and Hayashi, N., Impairment of natural killer cell and dendritic cell functions by the soluble form of MHC class I-related chain A in advanced human hepatocellular carcinomas. J. Hepatol. 2005. 43: 1013–1020.
33. Norris, S., Doherty, D. G., Curry, M. P., McEntee, G., Traynor, O., Hegarty, J. E. and O'Farrelly, C., Selective reduction of natural killer cells and T cells expressing inhibitory receptors for MHC class I in the livers of patients with hepatic malignancy. Cancer Immunol. Immunother. 2003. 52: 53–58.
34. Pugh, S. A., Harrison, R. J., Primrose, J. N. and Khakoo, S. I., T cells but not NK cells are associated with a favourable outcome for resected colorectal liver metastases. BMC Cancer 2014. 14: 180. doi: 10.1186/1471-2407-14-180.
35. Kelly, A., Fahey, R., Fletcher, J. M., Keogh, C., Carroll, A. G., Siddachari, R., Geoghegan, J. et al., CD141 + myeloid dendritic cells are enriched in healthy human liver. J. Hepatol. 2014. 60: 135–142.